1. Home
  2. Live Updates
  3. Blueprint medicines corp

Page 4 - Blueprint Medicines Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Blueprint medicines corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Blueprint Medicines Corp Today - Breaking & Trending Today

Blueprint Medicines Corp (BPMC) Reports Q3 2023 Earnings

Revenue Growth and Operational Efficiency Highlighted in Latest Financial Results ....

Kate Haviland , Company Outlook , Blueprint Medicines Corp , Company Cash Position , Medicines Corp , Cash Equivalents , Perational Efficiency , Product Revenues , Net Loss ,

Blueprint Medicines: Q3 Earnings Snapshot

CAMBRIDGE, Mass. (AP) CAMBRIDGE, Mass. (AP) Blueprint Medicines Corp. (BPMC) on Thursday reported a loss of $133.7 million in its third quarter. ....

United Kingdom , United States , Blueprint Medicines Corp , Zacks Investment Research , Blueprint Medicines , Wall Street , Automated Insights , Zacks Investment , Earns Blueprint Medicines ,

BPMC Stock Price | Blueprint Medicines Corp. Stock Quote (U.S.: Nasdaq)

BPMC | Complete Blueprint Medicines Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ....

Etby Jaimy Lee , Blueprint Medicines Corp , Blueprint Medicines , Pmc Analyst Estimates , Pmc Earnings Estimates , Pmc Share Estimates , Pmc Analyst Recommendations , Pmc Ratings , Lueprint Medicines Corp Analyst Estimates , Lueprint Medicines Corp Earnings Estimates , Lueprint Medicines Corp Analyst Recommendations , Lueprint Medicines Corp Analyst Ratings ,

Insider Sell: Fouad Namouni Sells 3,769 Shares of Blueprint Medicines Corp

On October 4, 2023, Fouad Namouni, President of R & D at Blueprint Medicines Corp (NASDAQ:BPMC), sold 3,769 shares of the company. ....

Blueprint Medicines Corp , Medicines Corp , Gurufocus Value , Iopharmaceutical Company , Fouad Namouni ,

Director Jeffrey Albers Sells 25,000 Shares of Blueprint Medicines Corp

On September 28, 2023, Jeffrey Albers, a director at Blueprint Medicines Corp (NASDAQ:BPMC), sold 25,000 shares of the company's stock. ....

Jeffrey Albers , Blueprint Medicines Corp , Gurufocus Value , Director Jeffrey Albers , Blueprint Medicines , Jeffrey Albers , Nsider Transactions , Blueprint Medicines Corp ,